Estée Lauder stock gains momentum as outlook rises after Q1 recovery

Estée Lauder reported stronger sales and profitability for the quarter ended September 30, 2026, and raised its fiscal 2027 outlook on November 2. The company said reported net sales increased 7% to 3.715 billion US dollars, while organic net sales rose 6%. The WBOC report reproduced the company announcement.

Sales And Margins Improve

Adjusted operating margin expanded to 12.1% from 7.3% in the prior-year quarter. Adjusted diluted earnings per share rose to 0.72 US dollars from 0.32 US dollars, while gross margin reached 75.7% from 73.3%.

Management attributed the improvement to operating leverage, procurement savings, manufacturing efficiencies, expense optimization and strategic pricing. Consumer-facing investment also increased, as the company continued to support product launches, marketing and distribution.

Fragrance Leads Category Growth

Fragrance was the strongest product category, with organic sales increasing 20% to 861 million US dollars. Growth came from luxury brands including Le Labo, TOM FORD, Jo Malone London and KILIAN PARIS, as well as the Estée Lauder brand.

Organic skin-care sales increased 4%, supported by La Mer and The Ordinary. Mainland China sales grew 15% on a reported basis, while Asia/Pacific sales rose 9%; growth also continued in the Americas and priority emerging markets.

Higher Guidance Sets Next Test

For fiscal 2027, Estée Lauder now expects organic net sales growth of 4.0% to 5.5%, adjusted operating margin of 12.9% to 13.7% and adjusted diluted earnings per share of 3.20 to 3.45 US dollars. The company previously expected organic sales growth of 3% to 5%, adjusted margin of 12.7% to 13.5% and adjusted earnings per share of 3.10 to 3.35 US dollars.

Estée Lauder stock traded at 99.75 euros on Lang & Schwarz at 11:00 p.m. CET on Wednesday, November 4, 2026. Investors can follow the real-time quote of Estée Lauder stock.

Global Prestige Beauty Portfolio

The Estée Lauder Companies manufactures, markets and sells skin-care, makeup, fragrance and hair-care products in approximately 150 countries and territories. Its portfolio includes Estée Lauder, Clinique, M·A·C, La Mer, Aveda, Jo Malone London, TOM FORD, Le Labo and The Ordinary. The company is positioned as a global manufacturer and seller of luxury and prestige beauty products, with business exposure across the Americas, Europe, Asia/Pacific and emerging markets.

The S&P 500 provides the broader US equity-market context for the company.

More news and analyses on Estée Lauder stock